Literature DB >> 24671390

Migraine and reward system-or is it aversive?

Catherine M Cahill1, Christopher Cook, Sarah Pickens.   

Abstract

Migraine is a debilitating neurological disorder with grave consequences for both the individual and society. This review will focus on recent literature investigating how brain structures implicated in reward and aversion contribute to the genesis of migraine pain. There exist many overlapping and interacting brain regions within pain and reward circuitry that contribute to negative affect and subjective experience of pain. The emotional component of pain has been argued to be a greater metric of quality of life than its sensory component, and thus understanding the processes that influence this pain characteristic is essential to developing novel treatment strategies for mitigating migraine pain. We emphasize and provide evidence that abnormalities within the mesolimbic cortical reward pathways contribute to migraine pain and that there are structural and functional neuroplasticity within the overlapping brain regions common to both pain and reward.

Entities:  

Mesh:

Year:  2014        PMID: 24671390     DOI: 10.1007/s11916-014-0410-y

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  99 in total

1.  Medical illness and the risk of suicide in the elderly.

Authors:  David N Juurlink; Nathan Herrmann; John P Szalai; Alexander Kopp; Donald A Redelmeier
Journal:  Arch Intern Med       Date:  2004-06-14

2.  Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder.

Authors:  Giacomo Salvadore; Allison C Nugent; Herve Lemaitre; David A Luckenbaugh; Ruth Tinsley; Dara M Cannon; Alexander Neumeister; Carlos A Zarate; Wayne C Drevets
Journal:  Neuroimage       Date:  2010-11-10       Impact factor: 6.556

Review 3.  Understanding migraine through the lens of maladaptive stress responses: a model disease of allostatic load.

Authors:  David Borsook; Nasim Maleki; Lino Becerra; Bruce McEwen
Journal:  Neuron       Date:  2012-01-26       Impact factor: 17.173

4.  Structural and functional abnormalities in migraine patients without aura.

Authors:  Chenwang Jin; Kai Yuan; Limei Zhao; Ling Zhao; Dahua Yu; Karen M von Deneen; Ming Zhang; Wei Qin; Weixin Sun; Jie Tian
Journal:  NMR Biomed       Date:  2012-06-07       Impact factor: 4.044

5.  Medical consultation for migraine: results from the American Migraine Study.

Authors:  R B Lipton; W F Stewart; D Simon
Journal:  Headache       Date:  1998-02       Impact factor: 5.887

6.  Headache triggers in the US military.

Authors:  Brett J Theeler; Kimbra Kenney; Olga A Prokhorenko; Ulgen S Fideli; William Campbell; Jay C Erickson
Journal:  Headache       Date:  2009-11-17       Impact factor: 5.887

Review 7.  Advances in the basic and clinical science of migraine.

Authors:  Andrew Charles
Journal:  Ann Neurol       Date:  2009-05       Impact factor: 10.422

8.  The missing link: enhanced functional connectivity between amygdala and visceroceptive cortex in migraine.

Authors:  Nouchine Hadjikhani; Noreen Ward; Jasmine Boshyan; Vitaly Napadow; Yumi Maeda; Andrea Truini; Francesca Caramia; Emanuele Tinelli; Caterina Mainero
Journal:  Cephalalgia       Date:  2013-05-29       Impact factor: 6.292

Review 9.  Neurobiological mechanisms of placebo responses.

Authors:  Jon-Kar Zubieta; Christian S Stohler
Journal:  Ann N Y Acad Sci       Date:  2009-03       Impact factor: 5.691

10.  Migraine attacks the Basal Ganglia.

Authors:  Nasim Maleki; Lino Becerra; Lauren Nutile; Gautam Pendse; Jennifer Brawn; Marcelo Bigal; Rami Burstein; David Borsook
Journal:  Mol Pain       Date:  2011-09-21       Impact factor: 3.395

View more
  8 in total

1.  Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain.

Authors:  Shiwei Steve Liu; Sarah Pickens; Nicole E Burma; Ines Ibarra-Lecue; Hongyan Yang; Lihua Xue; Chris Cook; Joshua K Hakimian; Amie L Severino; Lindsay Lueptow; Kristina Komarek; Anna M W Taylor; Mary C Olmstead; F Ivy Carroll; Caroline E Bass; Anne M Andrews; Wendy Walwyn; Tuan Trang; Christopher J Evans; Frances M Leslie; Catherine M Cahill
Journal:  J Neurosci       Date:  2019-03-12       Impact factor: 6.167

2.  Neuroinflammation-a co-occurring phenomenon linking chronic pain and opioid dependence.

Authors:  Catherine M Cahill; Anna Mw Taylor
Journal:  Curr Opin Behav Sci       Date:  2017-01-06

Review 3.  Does the kappa opioid receptor system contribute to pain aversion?

Authors:  Catherine M Cahill; Anna M W Taylor; Christopher Cook; Edmund Ong; Jose A Morón; Christopher J Evans
Journal:  Front Pharmacol       Date:  2014-11-17       Impact factor: 5.810

Review 4.  Reward Circuitry Plasticity in Pain Perception and Modulation.

Authors:  Marcos F DosSantos; Brenda de Souza Moura; Alexandre F DaSilva
Journal:  Front Pharmacol       Date:  2017-11-21       Impact factor: 5.810

5.  Altered neural activity to monetary reward/loss processing in episodic migraine.

Authors:  Natália Kocsel; Attila Galambos; Edina Szabó; Andrea Edit Édes; Máté Magyar; Terézia Zsombók; Dorottya Pap; Lajos Rudolf Kozák; György Bagdy; Gyöngyi Kökönyei; Gabriella Juhász
Journal:  Sci Rep       Date:  2019-04-01       Impact factor: 4.379

Review 6.  Modulation of the Negative Affective Dimension of Pain: Focus on Selected Neuropeptidergic System Contributions.

Authors:  Francesca Felicia Caputi; Laura Rullo; Serena Stamatakos; Sanzio Candeletti; Patrizia Romualdi
Journal:  Int J Mol Sci       Date:  2019-08-17       Impact factor: 5.923

7.  Dopaminergic Regulation of Reward System Connectivity Underpins Pain and Emotional Suffering in Migraine.

Authors:  Dajung J Kim; Hassan Jassar; Manyoel Lim; Thiago D Nascimento; Alexandre F DaSilva
Journal:  J Pain Res       Date:  2021-03-09       Impact factor: 3.133

Review 8.  Contributions of aversive environmental stress to migraine chronification: Research update of migraine pathophysiology.

Authors:  Tang-Hua Liu; Zhen Wang; Fang Xie; Yan-Qing Liu; Qing Lin
Journal:  World J Clin Cases       Date:  2021-03-26       Impact factor: 1.337

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.